![Steven A. Fischkoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven A. Fischkoff served as Vice President at Palatin Technologies, Inc. and as Chief Medical Officer at Iovance Biotherapeutics, Inc. He also held the position of VP-Clinical & Medical Affairs at Celgene Cellular Therapeutics.
Fischkoff earned a doctorate degree from the University of Pennsylvania.
| Sociétés | Poste | Fin |
|---|---|---|
| ADAGENE INC. | Directeur Technique/Scientifique/R&D | 02/02/2022 |
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/03/2017 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Corporate Officer/Principal | - |
| PALATIN TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Palatin Technologies, Inc.
 Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
